DPT and lung carcinoma: In this report, we demonstrated that DPT-1 and DPT-2 could be pro-apoptotic agents in lung carcinoma, the human lung carcinoma A549 and non-small lung carcinoma H1299, in the range of IC50 = 1.52–12.89 μM, with a protective potential to healthy cell lines BEAS-2B and NHDF.